Clinical Trials Logo

Filter by:
NCT ID: NCT03878680 Completed - Asthma Clinical Trials

Prevalence of Asthma and Allergies Among Children in UAE

ISAAC-UAE
Start date: April 30, 2019
Phase:
Study type: Observational

Multicenter, cross-sectional study to recruit a random sample of 6000 children via school class registers: 3000 children aged 13-14 years and 3000 children aged 6-7 years.

NCT ID: NCT03826888 Completed - Clinical trials for Anti-Mullerian Hormone Isoforms

Measurement of Different Anti-Müllerian Hormone Isoforms in Expected Poor Responders

Start date: February 25, 2019
Phase:
Study type: Observational

This study wants to evaluate significant clinical impact of different AMH isoforms in serum can be present or absent in expected poor responder participants. The specific AMH isoforms could therefore be measured in expected poor responder participants in order to obtain a more realistic clinical picture and therefore be able to give proper information to the participants and selection of medication dose for ovarian stimulation.

NCT ID: NCT03823339 Completed - Clinical trials for Diabetes Mellitus, Type 2

A Research Study, Looking at How Xultophy® Works in People With Type 2 Diabetes in Local Clinical Practice in United Arab Emirates

INTENSIFY
Start date: January 29, 2019
Phase:
Study type: Observational

The purpose of the study is to collect information on how Xultophy® works in patients with type 2 diabetes. The participants will get Xultophy® as prescribed to them by the study doctor. The study will last for about 26-34 weeks. The participants will be asked questions about their health and their diabetes treatment as part of their normal study doctor's appointment.

NCT ID: NCT03746275 Completed - Atherosclerosis Clinical Trials

Study to Gain Insights in Treatment Patterns and Outcomes in Patients With Atherosclerosis Prescribed to Xarelto in Combination With Acetylsalicylic Acid

XATOA
Start date: November 13, 2018
Phase:
Study type: Observational

In this study researchers want to gain more information on treatment patterns of patients treated with Xarelto in combination with acetylsalicylic acid (ASA). Both drugs reduce the risk of blood clots via different pathways. The study will enroll adult patients suffering from coronary artery disease (narrowing or blockage of vessels that supply the heart with blood) or peripheral artery disease (narrowing or blockage of vessels that supply the legs or head with blood). The study will focus on information on when and why physicians are starting to treat patients with Xarelto in addition to ASA, treatment duration, reasons to discontinue treatment and previous therapies. The study will also look into treatment outcomes for patients being treated with a combination of Xarelto and ASA by their physicians.

NCT ID: NCT03708991 Completed - Genetic Condition Clinical Trials

Effectiveness of PGT-A: IVF Versus ICSI

Start date: November 8, 2018
Phase:
Study type: Observational [Patient Registry]

The investigators want to investigate if the use of conventional in vitro fertilization (IVF) can generate more euploid embryos as compared to intracytoplasmic sperm injection (ICSI). To verify this, the investigators will inject half of the oocytes by ICSI and the other half of the oocytes will be inseminated by conventional IVF. The most important aim is to see if IVF is able to generate more euploid embryos.

NCT ID: NCT03703869 Completed - Diabetes Clinical Trials

Twelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo® After Oral Antidiabetic Drug Failure, the Side Effect of Toujeo®, and The Cost.

ATOS
Start date: March 6, 2018
Phase:
Study type: Observational

Primary Objective: Assess effectiveness of insulin glargine (U300) in achieving glycemic goal measured by hemoglobin A1c (HbA1c). Secondary Objectives: - Assess effectiveness in achieving glycemic goal measured by HbA1c; - Assess effectiveness on change in HbA1c, fasting plasma glucose (FPG) and self-monitored plasma glucose (SMPG) ; - Assess requirement for intensification of therapy by additional antidiabetics. - Assess incidence of hypoglycemia; - Assess other safety endpoints: adverse events (AEs), serious adverse events (SAEs); - Assess change in body weight.

NCT ID: NCT03686059 Completed - Clinical trials for Ocular Surface Disease

Outcome of Omega 3 FA and Punctal Plugs on Ocular Surface Disease

Start date: July 2, 2018
Phase: Phase 4
Study type: Interventional

Ocular surface disease is a common adverse effect of systemic isotretinoin therapy. The investigators consider that punctal plugs and Omega 3 is a good line for treatment of ocular surface disease associated with systemic isotretinoin therapy

NCT ID: NCT03681184 Completed - Clinical trials for Primary Hyperoxaluria Type 1 (PH1)

A Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1

ILLUMINATE-A
Start date: November 27, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of lumasiran in children and adults with primary hyperoxaluria type 1 (PH1).

NCT ID: NCT03607409 Completed - Infertility Clinical Trials

Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment

Start date: September 9, 2018
Phase:
Study type: Observational

To evaluate the role of Inhibin A as bio marker for the number of mature oocytes, compared to Estradiol

NCT ID: NCT03584191 Completed - Obesity Clinical Trials

Awareness, Care & Treatment In Obesity Management - An International Observation

ACTION-IO
Start date: June 4, 2018
Phase:
Study type: Observational

The purpose of this survey is to collect the data on perceptions, behaviours and awareness related to obesity and obesity management for People with Obesity (PwO) and Health Care Professionals (HCP) treating obesity. Data will be collected via online surveys among each of the respondent groups. The surveys are expected to take approximately 25 minutes to complete and will be unique for PwO and HCP. As a cross-sectional study, there will be no treatment of patients.